Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 63 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →
Share price
₹1,680.80
Market cap
₹97,621 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
24.8×Sector 47.4×
Promoter holding
51.88%+0.06% QoQ
FII holding
16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:53 IST BSE
Acquisition

Aurobindo Pharma Acquisition Worth ₹9.47 Cr

Aurobindo Pharma's subsidiary acquired A1 Biochem USA Inc for ₹9.47 Crore. This 100% acquisition expands its contract research and development services capabilities in the USA.

Value
₹9.47 Cr